Telephone and internet prescribers as well as compounding pharmacies are selling and mixing up these drugs for people to self-inject
*Semaglutide is a human glucagon-like peptide-1 (GLP-1) analogue produced in Saccharomyces cerevisiae cells by recombinant DNA technology
(Johnson has learned that his body temperature runs a few degrees Fahrenheit lower than the average
The supplemented mice gained significantly less weight, had lower fat mass, and showed increased energy expenditure compared to controls
It has been referenced in the literature as a next-generation advancement beyond dual-agonist peptide frameworks, studied in relation to glucose homeostasis, energy expenditure, lipid metabolism, and appetite signalling
Nader's comments contribute to a bigger conversation around the current state of GLP-1 drugs and the rising trend of microdosing them